Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Sees Significant Decrease in Short Interest

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 142,100 shares, a decrease of 65.1% from the June 15th total of 407,416 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 2,234,493 shares, the days-to-cover ratio is presently 0.1 days.

Advanced Medical Isotope Price Performance

Advanced Medical Isotope stock opened at $0.08 on Monday. Advanced Medical Isotope has a 12-month low of $0.04 and a 12-month high of $0.15. The company has a market capitalization of $40.46 million, a price-to-earnings ratio of -8.19 and a beta of -0.75. The firm’s fifty day moving average price is $0.07 and its 200 day moving average price is $0.07.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.